Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors

Clinical trial NCT07624214 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07624214
Sponsor: Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)Advanced Solid Tumors

Start date: 2026-07-01
Primary completion: 2028-04-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.